NIH Human Embryonic Stem Cell Registry - Research Using These Lines is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line:	UCLA 7; Patau syndrome/Trisomy 13
NIH Registration Number:	0143
NIH Approval Number:	NIHhESC-12-0143
Available for Distribution:	Yes
Provider Restrictions:	hESC recipients must provide documentation of of ESCRO, IRB, or equivalent ethical review for the reseach planned with the requested line.
Additional Information:	UCLA 7 (47, XX+13) was karyotyped at passage 7 after derivation. Cytogenic analysis of the resulting hESC line was performed on twenty G-banded metaphase cells and all twenty cells demonstrated trisomy 13. No other karyotypic abnormality was identified. Trisomy 13 is a genetic disorder also referred to as Patau syndrome.
NIH Restrictions:	(No Additional Restrictions)
Submitting Organization:	University of California, Los Angeles
Provider Name:	Steven Peckman
Provider Phone:	310-794-4919
Provider Email:	speckman@mednet.ucla.edu
Provider URL:	https://stemcell.ucla.edu
Approval Date:	01/12/2012

View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page

Related Resources

hESC Line Listings:

NIH Form 2890:

Login Page
(Authorization Required)

Stem Cell Information:

NIH Stem Cell Information Page

RSS Feed:

RSS Data Feed

Contact Us:

Email questions to:
hescregistry@mail.nih.gov